CCM
MDT icon

CFO Capital Management’s Medtronic MDT Stock Holding History

CFO Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$355K Buy
4,095
+970
+31% +$92.9K 0.29% 79
2025
Q4 		$300K Buy
+3,125
New +$304K 0.22% 88

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CFO Capital Management's MDT Position: Q1 2026 in Review

CFO Capital Management increased its Medtronic (MDT) stake by 31% in Q1 2026, buying an estimated $92.9K and bringing the position to 4,095 shares worth $355K. The position accounts for 0.29% of the portfolio, ranked #79.

CFO Capital Management first reported a position in MDT in Q4 2025 and has held it in 2 quarters since. 2,241 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • CFO Capital Management held 4,095 shares of Medtronic worth $355K as of Q1 2026.
  • CFO Capital Management bought 970 Medtronic shares in Q1 2026, an estimated $92.9K.
  • Medtronic made up 0.29% of CFO Capital Management's portfolio in Q1 2026, its #79 holding.
  • CFO Capital Management first reported a position in Medtronic in Q4 2025 and has held it in 2 quarters since.
  • 2,241 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on CFO Capital Management's 13F filing for Q1 2026, filed 4 May 2026.